Xeris Biopharma Holdings, Inc.

XERS · XNAS

CIK 1867096fmd_05KZDG0ZB229VZ7HDWTR3MW5YQManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Ratios computed from the standardized statements. Select a value to open its proof.